ArticleTherapeutic advances in medical oncology2024

Circulating tumor DNA-guided treatment decision in metastatic castration-resistant prostate cancer patients: a cost-effectiveness analysis.

Catharina J P Op 't Hoog et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.